Omega Therapeutics
Omega Therapeutics develops programmable epigenomic mRNA medicines for gene regulation and cellular function, utilizing the OMEGA platform to design epigenomic controllers.
Services
Omega Therapeutics develops programmable epigenomic mRNA medicines designed to regulate gene expression and cellular function. Using its proprietary OMEGA platform, the company creates epigenomic controllers that offer targeted therapeutic solutions. Key services include drug design leveraging computational genomics, machine learning, and artificial intelligence. Additionally, Omega Therapeutics provides lipid-nanoparticle delivery options for precise and efficient therapy.
Products
Omega Therapeutics creates mRNA therapeutics known as epigenomic controllers. These innovative products are designed using the OMEGA platform to target various biological, tissue, and disease types. Notably, the company maintains a comprehensive database of over 15,000 insulated genomic domains (IGDs), which helps identify precise therapeutic targets. Their lipid-nanoparticle delivery systems further enhance the accuracy and effectiveness of their medicinal products.
History
Omega Therapeutics was founded by Flagship Pioneering and is headquartered at 140 First Street, Suite 501, Cambridge, MA 02141. Since its inception, the company has focused on diseases that were previously considered elusive. Omega Therapeutics leverages advanced computational techniques and strong partnerships to accelerate the clinical development of their novel therapies.
Technologies
Omega Therapeutics employs several cutting-edge technologies in their drug design process. These include computational genomics, machine learning, and artificial intelligence. These tools enable the precise formulation of mRNA therapeutics and their corresponding epigenomic controllers. The company also utilizes lipid-nanoparticle delivery systems to ensure targeted and effective therapy.
Headquarters
Omega Therapeutics is headquartered at 140 First Street, Suite 501, Cambridge, MA 02141. This location serves as the central hub for their operations, including research and development, administrative functions, and collaborative partnerships.